SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-22-007713
Filing Date
2022-11-14
Accepted
2022-11-14 16:03:43
Documents
56
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q sonoma_i10q-093022.htm   iXBRL 10-Q 734021
2 CERTIFICATION sonoma_ex3101.htm EX-31.1 8752
3 CERTIFICATION sonoma_ex3102.htm EX-31.2 8548
4 CERTIFICATION sonoma_ex3201.htm EX-32.1 4818
  Complete submission text file 0001683168-22-007713.txt   3670976

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE snoa-20220930.xsd EX-101.SCH 26297
6 XBRL CALCULATION FILE snoa-20220930_cal.xml EX-101.CAL 49748
7 XBRL DEFINITION FILE snoa-20220930_def.xml EX-101.DEF 119949
8 XBRL LABEL FILE snoa-20220930_lab.xml EX-101.LAB 246670
9 XBRL PRESENTATION FILE snoa-20220930_pre.xml EX-101.PRE 199146
50 EXTRACTED XBRL INSTANCE DOCUMENT sonoma_i10q-093022_htm.xml XML 488951
Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301
Business Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

IRS No.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-33216 | Film No.: 221384990
SIC: 2834 Pharmaceutical Preparations